There's urgent need for awareness, immunisation against RSV in India: Doctors
Yet, RSV, often mistaken for a mild seasonal cold, is an under-discussed cause of lower respiratory tract infections in infants and children under five, he added.
Bengaluru, Jul 8 (PTI) Just in 2024 alone, respiratory syncytial virus (RSV) claimed 2,360 lives of children in hospitals notified in Bengaluru, Kolkata and Mumbai, said Dr Vasant M Khalatkar, National President of the Indian Academy of Pediatrics (IAP) on Tuesday.
'Only when you see outbreaks — like the one that happened in Kolkata in January — do testing occur,' he pointed out.
Dr Khalatkar was part of a three-member panel that participated in a roundtable discussion on the prevalence of RSV, organised by Dr Reddy's Laboratories Limited in Bengaluru on Tuesday.
Dr Reddy's is partnering with Sanofi, a French biopharma company, to bring to India single-dose preventive immunisation developed to protect infants from RSV-related complications.
Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr Reddy's, who was also part of the panel, said, 'RSV is the leading cause of respiratory illness in India, and when it deteriorates, it does so within three days of a cold-like symptom — from there on, the child develops serious complications like bronchiolitis and pneumonia.' He also quoted from a World Health Organization (WHO) study, which establishes that RSV is responsible for 63 per cent of acute respiratory infections in infants and young children worldwide.
At the roundtable discussion, the doctors also stated that by the time babies turn two years old, they are infected by RSV at least once. They held that there is no biomarker to determine which child will become seriously ill and develop pneumonia and bronchiolitis.
Representing Sanofi, Dr Cesar Mascarenas, Head of Medical International Region, said breast milk alone will not protect infants. 'The breastmilk is responsible for digestive tract-related immunity, while the placenta provides respiratory immunity, but this lasts about a month,' he said.
'We have long been working to close critical gaps in prevention by advancing science-driven solutions that align with evolving global recommendations, including those from the WHO,' added Mascarenas.
Dr Kotak said India bears a significant share of the global RSV burden.
'Unlike high-income countries with advanced prevention care and early access to preventive solutions, India still faces challenges in timely diagnosis and protection. Increased awareness around the severity of RSV and enabled access to ground-breaking immunisation solutions will be critical in building a more equitable and effective national response to RSV,' he added. PTI JR SA
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
Amarnath Yatra: City hospitals abuzz with pilgrims for ECG, blood sugar tests
With Amarnath pilgrims breaching one lakh mark within six days since it began, government hospitals in the temple city are also abuzz with yatris visiting for their health check ups. Pilgrims waiting to register themselves for the annual Amarnath Yatra in Jammu on Tuesday. (PTI) 'They are offline pilgrims, who are pouring here into Jammu city from various parts of the country. We are conducting their ECG and blood sugar tests,' said an official at Gandhi Nagar government hospital. The official informed that those with 'bad' results of their ECG and blood sugar levels are not being given clearance to undertake the pilgrimage. 'The doctors concerned are filling up the results in health certificates with their signature and seal,' he said. The official informed that apart from Gandhi Nagar government hospital, government hospital at Sarwal and Rajiv Gandhi Hospital in Babliana are also attending these pilgrims. 'The pilgrimage is arduous and the cave shrine is at an altitude of over 13,000 feet. Those with heart condition and diabetes cannot be allowed to undertake the pilgrimage,' he added. Amid health check ups of intending pilgrims, the yatra crossed one lakh mark on Tuesday since it began on July 3. 'The figures are constantly spiralling. There is no let up in enthusiasm among the devotees. Pahalgam attack has failed to create any fear among us,' said Krishna Yadav, 46, a pilgrim from Patna. Sheetal Devi, 41, another pilgrim from Azamgarh, said she has come for undergoing the tests. 'The staff at the hospital is very cooperative. They are guiding us properly. I eagerly look forward to undertake the yatra,' she said. The Pahalgam attack on April 22 had left 26 people dead and scores injured. On July 3, more than 12,000 pilgrims had paid obeisance at the cave shrine. Meanwhile, a fresh batch of over 7,500 pilgrims left Bhagwati Nagar base camp here early Tuesday for the 3,880-metre-high cave shrine of Amarnath in south Kashmir Himalayas. The 38-day pilgrimage commenced via the twin tracks — the traditional 48-km-long Nunwan-Pahalgam route in Anantnag district and the 14-km shorter but steeper Baltal route in Ganderbal district. The yatra will conclude on August 9. The seventh batch of 7,541 pilgrims, including 5,516 men and 1,765 women, left the Bhagwati Nagar base camp here in 309 vehicles for the twin base camps in Kashmir. The first pilgrim convoy, carrying 3,321 pilgrims in 148 vehicles, left for the 14-km Baltal route, followed by the second convoy of 4,220 pilgrims in 161 vehicles who are undertaking the yatra via the 48-km traditional Pahalgam route in Anantnag district. There is a huge rush at the counters for on-the-spot registration, with authorities increasing the number of counters to 15 from 12, as well as the daily quota to 4,100 to ease the rush. Over 4,000 devotees arrived in Jammu from various parts of the country to get themselves registered. More than 3.5 lakh people have registered online for the pilgrimage so far. Thirty-four accommodation centres have been set up across Jammu, and Radio Frequency Identification (RFID) tags are being issued to the pilgrims. Twelve counters have been set up for on-the-spot registration.
The Print
2 hours ago
- The Print
Haryana CMOs directed to track abortions of up to 24 weeks of pregnancy to curb ‘illegal' practices
A comprehensive procedure for reverse tracking has already been shared with all CMOs, an official statement said. The government aims to identify medical practitioners involved in 'illegal' procedures and initiate strict action for them. Chandigarh, Jul 8 (PTI) Haryana's additional chief secretary (Health) has directed chief medical officers (CMOs) to initiate reverse tracking of abortions conducted up to 24 weeks of pregnancy. A weekly meeting of the State Task Force (STF) for improving sex ratio in Haryana was held under the chairmanship of Rajpal here on Tuesday. The meeting focused on intensifying efforts to curb illegal abortions and further improve the state's sex ratio under the 'Beti Bachao-Beti Padhao' campaign. The meeting noted the recent improvement in Haryana's sex ratio to 904 till July 7 this year from 903 in the corresponding period last year. Rajpal emphasised the need for stringent enforcement against illegal abortions, instructing officials to take strict punitive measures, including revoking the licences of doctors found complicit. In one such case, two nursing homes were sealed in Nuh district over illegal abortion practices. Further, all CMOs have been asked to take action against the doctors and quacks engaged in illegal abortion activities and submit a report every week. The officials who took part in the meeting informed the additional chief secretary (ACS) that consistent field-level efforts have led to a noticeable rise in birth registration figures for June as compared to May. To further strengthen the drive, the ACS directed senior officers to collaborate with Accredited Social Health Activists (ASHA) and anganwadi workers to identify and register unregistered children, particularly in slum and low-income areas of Palwal, Nuh, Gurugram, and Faridabad. The goal is to complete all pending registrations within one month. Regarding the regulation of IVF centres, the STF decided that couples with one or two living female children seeking another child through IVF must obtain prior permission from the District Appropriate Authority. The meeting was also informed that due to an intensified crackdown on illegal Medical Termination of Pregnancy (MTP) centres, around 500 such centres have been shut down across the state. This has also led to a significant decline in legal MTPs over the past two months. The woman and child development department shared that awareness campaigns under the 'Beti Bachao, Beti Padhao initiative are being actively carried out in public parks, and telecom companies are being engaged to disseminate the message through phone alerts. Health Secretary and National Health Mission Mission Director Rippudaman Singh Dhillon and senior officers of various departments were present in the meeting. PTI SUN SKY SKY This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
The Print
10 hours ago
- The Print
There's urgent need for awareness, immunisation against RSV in India: Doctors
According to Dr Khalatkar, the 2024 data is just the tip of the ice-berg: although it has been a notifiable infection for almost five decades, people do not test for it. Yet, RSV, often mistaken for a mild seasonal cold, is an under-discussed cause of lower respiratory tract infections in infants and children under five, he added. Bengaluru, Jul 8 (PTI) Just in 2024 alone, respiratory syncytial virus (RSV) claimed 2,360 lives of children in hospitals notified in Bengaluru, Kolkata and Mumbai, said Dr Vasant M Khalatkar, National President of the Indian Academy of Pediatrics (IAP) on Tuesday. 'Only when you see outbreaks — like the one that happened in Kolkata in January — do testing occur,' he pointed out. Dr Khalatkar was part of a three-member panel that participated in a roundtable discussion on the prevalence of RSV, organised by Dr Reddy's Laboratories Limited in Bengaluru on Tuesday. Dr Reddy's is partnering with Sanofi, a French biopharma company, to bring to India single-dose preventive immunisation developed to protect infants from RSV-related complications. Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr Reddy's, who was also part of the panel, said, 'RSV is the leading cause of respiratory illness in India, and when it deteriorates, it does so within three days of a cold-like symptom — from there on, the child develops serious complications like bronchiolitis and pneumonia.' He also quoted from a World Health Organization (WHO) study, which establishes that RSV is responsible for 63 per cent of acute respiratory infections in infants and young children worldwide. At the roundtable discussion, the doctors also stated that by the time babies turn two years old, they are infected by RSV at least once. They held that there is no biomarker to determine which child will become seriously ill and develop pneumonia and bronchiolitis. Representing Sanofi, Dr Cesar Mascarenas, Head of Medical International Region, said breast milk alone will not protect infants. 'The breastmilk is responsible for digestive tract-related immunity, while the placenta provides respiratory immunity, but this lasts about a month,' he said. 'We have long been working to close critical gaps in prevention by advancing science-driven solutions that align with evolving global recommendations, including those from the WHO,' added Mascarenas. Dr Kotak said India bears a significant share of the global RSV burden. 'Unlike high-income countries with advanced prevention care and early access to preventive solutions, India still faces challenges in timely diagnosis and protection. Increased awareness around the severity of RSV and enabled access to ground-breaking immunisation solutions will be critical in building a more equitable and effective national response to RSV,' he added. PTI JR SA This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
